Your search returned 11 studies. (Get alerts for new studies):
- A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma - Adult Lymphocyte Predominant Hodgkin Lymphoma - Adult Mixed Cellularity Hodgkin Lymphoma - Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma - Adult Nodular Sclerosis Hodgkin Lymphoma - Recurrent Adult Hod 1 Location available
- Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL
Conditions: NHL - Lymphoma, Non-Hodgkin - Lymphoma, B-Cell - Lymphoma, Follicular - Lymphoma, Intermediate-Grade - Lymphoma, Large-Cell - Lymphoma, Low-Grade - Lymphoma, Mixed-Cell - Lymphoma, Small-Cell - Leukemia, Lymphocytic, Chronic - Leukemia, B-Cell, Chronic - 4 Locations available
- Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell
Conditions: Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Adult Diffuse Mixed Cell Lymphoma - Recurrent Adult Diffuse Small Cleaved Cell Lymphoma - Recurrent Grade 3 Follicular Lymphoma - Recurrent Mantle Cell Lymphoma 1 Location available
- Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for R
Conditions: Mucosa-Associated Lymphoid Tissue Lymphoma - Monocytoid B-cell Lymphoma - Recurrent Adult Burkitt's Lymphoma - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Adult Diffuse Mixed Cell Lymphoma - Recurrent Adult Diffuse Small Cleaved Cell Lymphoma 1 Location available
- Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant for Non-Hodgkin Lymphoma
Conditions: Anaplastic Large Cell Lymphoma - Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma - Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma - Contiguous Stage II Grade 1 Follicular Lymphom 1 Location available
- Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma - Adult Lymphocyte Predominant Hodgkin Lymphoma - Adult Mixed Cellularity Hodgkin Lymphoma - Adult Nodular Sclerosis Hodgkin Lymphoma - Stage II Adult Hodgkin Lymphoma - Stage III Adult Hodgkin Lymphoma - Stage 1 Location available
- Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
Conditions: Adult Acute Lymphoblastic Leukemia - Adult Acute Myeloid Leukemia - Adult Burkitt Lymphoma - Adult Diffuse Large Cell Lymphoma - Adult Diffuse Mixed Cell Lymphoma - Adult Diffuse Small Cleaved Cell Lymphoma - Adult Hodgkin Lymphoma - Adult Immunoblastic L 1 Location available
- Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma
Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma - Adult Lymphocyte Predominant Hodgkin Lymphoma - Adult Mixed Cellularity Hodgkin Lymphoma - Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma - Adult Nodular Sclerosis Hodgkin Lymphoma - Recurrent Adult Hod 1 Location available
- Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Auto
Conditions: Adult Non-Hodgkin Lymphoma - Adult Grade III Lymphomatoid Granulomatosis - Contiguous Stage II Adult Burkitt Lymphoma - Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma - Contiguous Stage II Adu 1 Location available
- Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Lymphoid Malignancies and Select Un
Conditions: Adult Grade III Lymphomatoid Granulomatosis - Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Chronic Lymphocytic Leukemia - Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma - Con 1 Location available
- High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Ly
Conditions: Post-transplant Lymphoproliferative Disorder - Recurrent Adult Burkitt Lymphoma - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Adult Diffuse Mixed Cell Lymphoma - Recurrent Adult Grade III Lymphomatoid Granulomatosis - Recurrent Adult Immunobla 1 Location available
|